MARÓDI, László. The creation and progress of the J Project in Eastern and Central Europe. Online. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2011, Neuveden, č. 1238, s. 65–73. ISSN 0077-8923. Dostupné z: https://dx.doi.org/10.1111/j.1749-6632.2011.06247.x. [citováno 2024-04-23]
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The creation and progress of the J Project in Eastern and Central Europe
Autoři MARÓDI, László
Vydání ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2011, 0077-8923.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30300 3.3 Health sciences
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.155
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1111/j.1749-6632.2011.06247.x
UT WoS 000299397400008
Klíčová slova anglicky primary immunodeficiency; network; genetic technologies; socioeconomic conditions
Příznaky Mezinárodní význam
Změnil Změnil: Mgr. Michal Petr, učo 65024. Změněno: 13. 4. 2012 11:14.
Anotace
Primary immunodeficiencies (PIDs)havenowbecomerecognized as aworldwide health problem. Rapid development of immunological and genetic technologies has led to the discovery of more than 200 PIDs andmore than 150 diseaserelated genes. Progress in the field is expected to take a new turn after the introduction of new-generation sequencing technologies that will enable searches for currently unknown PID-related genes. By contrast, even with progress in molecular genetics, many patients remain ill and die early because of the lack of diagnostic or treatment facilities, or both. Thus, the gap between the knowledge accumulated and the appropriate management of patients with PIDs in everyday clinical practice has widened, necessitating PID awareness, particularly in countries with poor socioeconomic conditions. The J Project, established as a physician education and research collaboration program in Eastern and Central Europe, demonstrates how professional responsibility and long-term joint efforts can make a beneficial difference for patients with inborn errors of immunity.
VytisknoutZobrazeno: 23. 4. 2024 18:01